Detalhe da pesquisa
1.
Complement activation in individuals with previous subclinical Lyme borreliosis and patients with previous Lyme neuroborreliosis.
Eur J Clin Microbiol Infect Dis
; 39(5): 855-862, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31893341
2.
Celiac disease and complement activation in response to Streptococcus pneumoniae.
Eur J Pediatr
; 179(1): 133-140, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31691001
3.
Complement Receptor 2 is increased in cerebrospinal fluid of multiple sclerosis patients and regulates C3 function.
Clin Immunol
; 166-167: 89-95, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27085202
4.
Discrepancies in plasma levels of complement components measured by a newly introduced commercially available magnetic bead technique compared to presently available clinical reference intervals.
Scand J Immunol
; 91(2): e12831, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31536648
5.
Development and evaluation of cationic amphiphilic antimicrobial 2,5-diketopiperazines.
J Pept Sci
; 24(7): e3090, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29845683
6.
Heme Interferes With Complement Factor I-Dependent Regulation by Enhancing Alternative Pathway Activation.
Front Immunol
; 13: 901876, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35935964
7.
Quantification of Complement Proteins with Special Reference to C1q: Multiplex Versus ELISA Versus Rocket Immunoelectrophoresis Versus Nephelometry.
Methods Mol Biol
; 2227: 33-41, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33847928
8.
The Complex Relationship between C4b-Binding Protein, Warfarin, and Antiphospholipid Antibodies.
Thromb Haemost
; 121(10): 1299-1309, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33412597
9.
Assessment of the Role of C3(H2O) in the Alternative Pathway.
Front Immunol
; 11: 530, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32296436
10.
Evaluation of a Novel Immunoassay for Quantification of C1q for Clinical Diagnostic Use.
Front Immunol
; 10: 7, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30740097
11.
Current and Future Approaches for Monitoring Responses to Anti-complement Therapeutics.
Front Immunol
; 10: 2539, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31787968
12.
Is generation of C3(H2O) necessary for activation of the alternative pathway in real life?
Mol Immunol
; 114: 353-361, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31446306
13.
Interpretation of Serological Complement Biomarkers in Disease.
Front Immunol
; 9: 2237, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30405598
14.
A model to study complement involvement in experimental retinal degeneration.
Ups J Med Sci
; 123(1): 28-42, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29436895
15.
Complement activation in Lyme neuroborreliosis--increased levels of C1q and C3a in cerebrospinal fluid indicate complement activation in the CNS.
J Neuroimmunol
; 183(1-2): 200-7, 2007 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-17157926
16.
The link between morphology and complement in ocular disease.
Mol Immunol
; 89: 84-99, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28622910
17.
Reciprocal relationship between contact and complement system activation on artificial polymers exposed to whole human blood.
Biomaterials
; 77: 111-9, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26584351
18.
TiO2 nanoparticles tested in a novel screening whole human blood model of toxicity trigger adverse activation of the kallikrein system at low concentrations.
Biomaterials
; 51: 58-68, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25770998
19.
Low concentrations of citrate reduce complement and granulocyte activation in vitro in human blood.
Clin Kidney J
; 8(1): 31-7, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25713707
20.
Prediction of inflammatory responses induced by biomaterials in contact with human blood using protein fingerprint from plasma.
Biomaterials
; 36: 55-65, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25292422